Robert Philibert
Technik-/Wissenschafts-/F&E-Leiter bei CARDIO DIAGNOSTICS HOLDINGS, INC.
Vermögen: 1 Mio $ am 30.04.2024
Profil
Robert Philibert is the founder of Behavioral Diagnostics, LLC (founded in 2009) and Cardio Diagnostics, Inc. (founded in 2017).
He is currently the Chief Medical Officer & Director at Cardio Diagnostics Holdings, Inc. (since 2022) and a Professor at the University of Iowa (since 1998).
He completed his undergraduate degree at the University of Iowa.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
01.04.2024 | 1 649 792 ( 7,64% ) | 1 Mio $ | 30.04.2024 |
Aktive Positionen von Robert Philibert
Unternehmen | Position | Beginn |
---|---|---|
CARDIO DIAGNOSTICS HOLDINGS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 25.10.2022 |
Cardio Diagnostics, Inc.
Cardio Diagnostics, Inc. Medical/Nursing ServicesHealth Services Part of Cardio Diagnostics Holdings, Inc., Cardio Diagnostics, Inc. is a biotechnology company based in Chicago, IL. The company is focused on making cardiovascular disease prevention and early detection more accessible, personalized, and precise. The company's flagship solution, the Cardio Diagnostics Epi+Gen CHD™ test, helps clinicians better assess each patient's unique risk profile for disease. The company's vision is to transform medical care for cardiovascular disease from reactive to proactive. Cardio Diagnostics was founded in 2017 by Meeshanthini Dogan and Robert Philibert, with Meeshanthini Dogan serving as CEO since then. Cardio Diagnostics was acquired by Mana Capital Acquisition Corp. on October 25, 2022 for $61.51 million. | Gründer | 01.05.2017 |
University of Iowa | Corporate Officer/Principal | 01.01.1998 |
Ehemalige bekannte Positionen von Robert Philibert
Unternehmen | Position | Ende |
---|---|---|
Behavioral Diagnostics, LLC | Gründer | - |
Ausbildung von Robert Philibert
University of Iowa | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
CARDIO DIAGNOSTICS HOLDINGS, INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
Cardio Diagnostics, Inc.
Cardio Diagnostics, Inc. Medical/Nursing ServicesHealth Services Part of Cardio Diagnostics Holdings, Inc., Cardio Diagnostics, Inc. is a biotechnology company based in Chicago, IL. The company is focused on making cardiovascular disease prevention and early detection more accessible, personalized, and precise. The company's flagship solution, the Cardio Diagnostics Epi+Gen CHD™ test, helps clinicians better assess each patient's unique risk profile for disease. The company's vision is to transform medical care for cardiovascular disease from reactive to proactive. Cardio Diagnostics was founded in 2017 by Meeshanthini Dogan and Robert Philibert, with Meeshanthini Dogan serving as CEO since then. Cardio Diagnostics was acquired by Mana Capital Acquisition Corp. on October 25, 2022 for $61.51 million. | Health Services |
Behavioral Diagnostics, LLC |